European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. For manufacturers, this allows for greater protection of products courtesy of real-time tracking data and the ability to refine and secure supply chains by spotting weak links.

Pharmaceutical 104

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 104

Impetus Digital

AUGUST 2, 2024

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. Regulatory Compliance Regulatory frameworks are continuously evolving in the pharmaceutical industry.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

PM360

AUGUST 9, 2022

According to an August 2021 report from the Business Research Company , after experiencing a decline in 2020 due to pandemic, the medication adherence market is expected to recover and grow at a compound annual growth rate (CAGR) of 11.4% KEEP was named in the top 100 best inventions list in TIME magazine following its launch in 2020.

Prescription 105

Prescription Medical Patients Side effects 105

European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions. pdf; 21 C.F.R. 562, 117th Cong. §

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 billion in 2020 and will project growth of USD 4.18 billion during 2020-2024. The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. from 2023 to 2030.

Pharma 52

Pharma Medicine Marketing Prospecting 52

World of DTC Marketing

AUGUST 12, 2022

In 2020 JAMA found that the estimated median capitalized research and development cost per product was $985 million, counting expenditures on failed trials. Meanwhile, the top 25 pharmaceutical companies reported a “healthy average operating margin of 22 percent” at the end of 2017, according to an analysis by GlobalData.

Pharma 255

Pharma Retail Pharmaceutical Pharmaceutical manufacturing 255

PM360

DECEMBER 20, 2023

During the application stage, manufacturers should formulate principles and prepare a value dossier which is structuralized in a similar way as a classic payer value story. The content of the value dossier should consist of product introduction, effectiveness, novelty, safety, economic value, and equity. Kapusniak, C. Rémuzat, Y.

Marketing 105

Marketing Insurance Medical Manufacturing 105